Kala Pharmaceuticals, Inc. - KALA

About Gravity Analytica
Recent News
- 02.12.2025 - KALA BIO Announces Chief Executive Officer Transition
- 12.30.2024 - KALA BIO Announces $10,750,000 Private Placement
- 12.04.2024 - Piper Sandler 36th Annual Healthcare Conference
Recent Filings
- 02.12.2025 - 8-K Current report
- 02.04.2025 - 424B3 Prospectus [Rule 424(b)(3)]
- 02.04.2025 - EFFECT Notice of Effectiveness
- 01.24.2025 - S-3 Registration statement under Securities Act of 1933
- 01.10.2025 - 4/A Statement of changes in beneficial ownership of securities
- 01.07.2025 - 4 Statement of changes in beneficial ownership of securities
- 01.07.2025 - 4 Statement of changes in beneficial ownership of securities
- 01.07.2025 - 4 Statement of changes in beneficial ownership of securities
- 01.07.2025 - 4 Statement of changes in beneficial ownership of securities
- 01.07.2025 - 4 Statement of changes in beneficial ownership of securities